Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?

An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"

10 December 2012 (Monday), 2pm
College of Dentistry Auditorium (map; entrance via Pedro Gil St)
University of the Philippines Manila

Webpage shortcut: goo.gl/xszDH

Online Registration is now closed.

Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA

Organizers

• PGC ELSI Program
• UP Manila Research Ethics Board
• UP Manila National Institutes of Health

Program

Welcome Remarks
Dr. Vicente Y. Belizario, Jr.
Executive Director, UP Manila National Institutes of Health

Opening Remarks
Dr Carmencita David Padilla
Executive Director, Philippine Genome Center

Presentations
"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
Dr Reidar K. Lie
Adjunct Research Fellow, US NIH

"Reviewing Genetic and Genomic Research: Issues and Challenges"
Dr Leslie Michelle M. Dalmacio
UP Manila Research Ethics Board

Reactor Dr Filipinas Natividad
VP for Research and Biotechnology Division, St Luke's Medical Ctr

Open Discussions Prof. Peter A. Sy (Moderator)
PGC ELSI Program Director

Closing Remarks
Dr. Jacinto Blas Mantaring III
UPMREB Chair

Dr. Marita V. Reyes
Scientific Adviser, PGC ELSI Program

Inquiries

Please direct them to
psy@kssp.upd.edu.ph

Emergency matters: Val (#), Ribi (#)

See Also

“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center